Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Coping with Multiple Sclerosis Scale: Reconsideration of the Factorial Structure.
Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial.
[A treatment of neuromyelitis optica (Devic's disease) during pregnancy].
Lithium to the Rescue.
Anthraquinones As Pharmacological Tools and Drugs.
Analysis of the neuroregenerative activities of mesenchymal stem cells in functional recovery after rat spinal cord injury.
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology.
IVIg attenuates complement and improves spinal cord injury outcomes in mice.
Regenerative Capacity of Macrophages for Remyelination.
A review of the ethics of the use of placebo in clinical trials for relapsing-remitting multiple sclerosis therapeutics.
NG2-glia, More Than Progenitor Cells.
Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.
Systematic, Evidence-Based Review of Exercise, Physical Activity, and Physical Fitness Effects on Cognition in Persons with Multiple Sclerosis.
Clinical significance of Tim3-positive T cell subsets in patients with multiple sclerosis.
The Role of Biogenic Amines in the Regulation of Interaction between the Immune and Nervous Systems in Multiple Sclerosis.
Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia.
Magnetization transfer imaging reveals geniculocalcarine and striate area degeneration in primary glaucoma: a preliminary study.
Default mode network changes in multiple sclerosis: a link between depression and cognitive impairment?
Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis.
A multi-biomarker follow-up study of patients with multiple sclerosis.
Stroke induces specific alteration of T memory compartment controlling auto-reactive CNS antigen-specific T cell responses.
Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients.
Effectiveness and safety of natalizumab in real-world clinical practice: Review of observational studies.
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
Pages
« first
‹ previous
…
738
739
740
741
742
743
744
745
746
…
next ›
last »